Author details

Full Name

Xuya Wang

Affiliation

ORCID

Career Start Year

2013

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36434176	PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma.	Cancer Gene Therapy	2023
35151844	HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion.	Mol Ther	2022
36044718	Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and Function.	JCO Precis Oncol	2022
35756689	A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma.	Frontiers in Oncology	2022
35977756	Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial.	J Immunother Cancer	2022
34992215	TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas.	Cancer Gene Therapy	2022
35169076	LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint.	Proc Natl Acad Sci U S A	2022
34211612	MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.	Disease Markers	2021
32483429	ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.	Theranostics	2020
31666291	Comprehensive Scanning Mutagenesis of Human Retrotransposon LINE-1 Identifies Motifs Essential for Function.	Genetics	2019
29802231	Transcription factor profiling reveals molecular choreography and key regulators of human retrotransposon expression.	Proc Natl Acad Sci U S A	2018
29472518	Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers.	Cancer Res	2018
28269880	A First Step towards a Clinical Decision Support System for Post-traumatic Stress Disorders.	AMIA Annu Symp Proc	2017
28348404	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.	Nat Commun	2017
28790197	Breast tumors educate the proteome of stromal tissue in an individualized but coordinated manner.	Sci Signal	2017
28440318	Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.	Nat Commun	2017
28280154	Synthesis, debugging, and effects of synthetic chromosome consolidation: synVI and beyond.	Science	2017
28280152	Bug mapping and fitness testing of chemically synthesized chromosome X.	Science	2017
28280151	"Perfect" designer chromosome V and behavior of a ring derivative.	Science	2017
26631509	An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.	Mol Cell Proteomics	2016
25257758	Regulation of CTR2 mRNA by the nonsense-mediated mRNA decay pathway.		2014
23450501	Physiological basis of copper tolerance of Saccharomyces cerevisiae nonsense-mediated mRNA decay mutants.	Yeast	2013